Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program

BACKGROUND: Intravenous immune globulin (IVIG) is an expensive and sometimes scarce blood product that carries some risk. It may often be used inappropriately. We evaluated the appropriateness of IVIG use before and after the introduction of an utilization control program to reduce inappropriate use...

Descripción completa

Detalles Bibliográficos
Autores principales: Feasby, Thomas E, Quan, Hude, Tubman, Michelle, Pi, David, Tinmouth, Alan, So, Lawrence, Ghali, William A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Medicine Publications, Inc. 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329117/
https://www.ncbi.nlm.nih.gov/pubmed/22567080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329117/
https://www.ncbi.nlm.nih.gov/pubmed/22567080

Ejemplares similares